Contineum Therapeutics, Inc. Class A Common Stock (CTNM) market cap is $429.6M
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) market cap is $429.6M as of 2024-09-30. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full CTNM research page for quote, filings, and the rest of the model. This satellite exists so “Contineum Therapeutics, Inc. Class A Common Stock market cap” can rank with the actual number, then send you to /stock/ctnm.